Sentinel lymph node biopsy with a gamma probe in patients with high-risk cutaneous squamous cell carcinoma: follow-up results of sentinel lymph node-negative patients

DEMİR, HAKAN; Isken, Tonguc; Kus, Evrim; Tan, Yusuf; İŞGÖREN, SERKAN; Gorur, GÖZDE; Oc, Alper; Sen, Cenk; Cek, Deniz; Ercin, Cengiz; Berk, Fatma

doi:10.1097/mnm.0b013e32834b76cf

Sentinel lymph node biopsy with a gamma probe in patients with high-risk cutaneous squamous cell carcinoma: follow-up results of sentinel lymph node-negative patients

Atıf İçin Kopyala

DEMİR H., Isken T., Kus E., Tan Y. Z., İŞGÖREN S., Gorur G., ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.32, sa.12, ss.1216-1222, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Sayı: 12
Basım Tarihi: 2011
Doi Numarası: 10.1097/mnm.0b013e32834b76cf
Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1216-1222
Anahtar Kelimeler: cutaneous squamous cell carcinoma, gamma probe, high risk, lymphoscintigraphy, sentinel lymph node biopsy, VULVAR CANCER, MELANOMA, LYMPHOSCINTIGRAPHY, NECK, SKIN, LOCALIZATION, METASTASES, UPDATE, HEAD
Kocaeli Üniversitesi Adresli: Evet

Özet

Objective Lymphoscintigraphy (LS) and sentinel lymph node biopsy have become the standard of care for melanoma and breast cancer. However, the data on patients with cutaneous squamous cell carcinoma (SCC) are limited. We aimed to evaluate and identify the role of LS and sentinel lymph node biopsy in patients with high-risk cutaneous SCC.